Fatemeh Rahimi, Ashraf Zarvani, Farzad Fayedeh, Athena Sharifi-Razavi. Low-dose vs. standard-dose alteplase for acute ischemic stroke: a retrospective cohort study of safety and efficacy in an Iranian population. // BMC Neurology. – 2025. – DOI: 10.1186/s12883-025-04413-z. – URL: https://doi.org/10.1186/s12883-025-04413-z
Fatemeh Rahimi, Ashraf Zarvani, Farzad Fayedeh, & Athena Sharifi-Razavi (2025). Low-dose vs. standard-dose alteplase for acute ischemic stroke: a retrospective cohort study of safety and efficacy in an Iranian population. BMC Neurology. https://doi.org/10.1186/s12883-025-04413-z
Fatemeh Rahimi, et al. “Low-dose vs. standard-dose alteplase for acute ischemic stroke: a retrospective cohort study of safety and efficacy in an Iranian population.” BMC Neurology, 2025. doi:10.1186/s12883-025-04413-z.
@article{Rahimi2025,
title = {Low-dose vs. standard-dose alteplase for acute ischemic stroke: a retrospective cohort study of safety and efficacy in an Iranian population},
author = {Rahimi, Fatemeh and Zarvani, Ashraf and Fayedeh, Farzad and Sharifi-Razavi, Athena},
journal = {BMC Neurology},
year = {2025},
doi = {10.1186/s12883-025-04413-z},
url = {https://doi.org/10.1186/s12883-025-04413-z}
}